Shareholder Alert: Ademi LLP Investigates Whether AgeX Therapeutics, Inc. Has Obtained a Fair Price in Its Transaction With Serina
Shareholder Alert: Ademi LLP Investigates Whether AgeX Therapeutics, Inc. Has Obtained a Fair Price in Its Transaction With Serina
MILWAUKEE, Aug. 30, 2023 /PRNewswire/ -- Ademi LLP is investigating AgeX (NYSE American: AGE) for possible breaches of fiduciary duty and other violations of law in its transaction with Serina.
密尔沃基，2023年8月30日/美通社/--Ademi LLP正在调查AgeX(纽约证券交易所美国股票代码：AGE)在与Serina的交易中可能违反受托责任和其他违法行为。
Click here to learn how to join the or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
单击此处了解如何加入或呼叫古里·阿德米免费电话：866-264-3995。对你来说没有任何费用或义务。
Upon completion of the merger, pre-merger AgeX stockholders are expected to own approximately 25% of the newly combined company while pre-merger Serina stockholders are expected to own approximately 75% of the newly combined company. AgeX insiders will receive substantial benefits as part of change of control arrangements. In addition, AgeX will issue to each AgeX stockholder three warrants for each five shares of AgeX common stock held by such stockholder (each a "Post-Merger Warrant"). Each Post-Merger Warrant will be exercisable for one unit at a price equal to $13.20 and will expire on July 31, 2025. Each unit will consist of (i) one share of common stock of AgeX and (ii) one warrant (each such warrant, an "Incentive Warrant") that will be exercisable to purchase one share of common stock of AgeX at a price equal to $18.00 and that will expire in four years.
合并完成后，预计合并前的AgeX股东将拥有新合并公司约25%的股份，而合并前的Serina股东预计将拥有新合并公司约75%的股份。作为控制权变更安排的一部分，AgeX内部人士将获得可观的利益。此外，AgeX将向每一位AgeX股东每持有五股AgeX普通股发行三份认股权证(每份为“合并后认股权证”)。每个合并后的认股权证将以一个单位的价格行使，价格等于13.20美元并将于以下日期到期2025年7月31日。每个单位将包括(I)一股AgeX普通股和(Ii)一份认股权证(每一种认股权证，“激励权证”)，该认股权证将可行使，以购买一股AgeX普通股，价格等于18.00美元而这一期限将在四年后到期。
We are investigating the conduct of AgeX's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
我们正在调查AgeX董事会的行为，以及他们是否履行了对所有股东的受托责任。
If you own AgeX common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or
如果您持有AgeX普通股，并希望获得更多信息，请联系古里·阿德米无论是在[受电子邮件保护]或免费：866-264-3995，或
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
我们专门处理涉及收购、合并和全国各地的个人股东权利的股东诉讼。如需更多信息，请随时致电我们。律师广告。以前的结果并不能保证类似的结果。
Contacts
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
Contacts
Ademi LLP
古里·阿德米
免费电话：(866)264-3995
传真：(414)482-8001
SOURCE Ademi LLP
来源：ADEMI LLP